Bukwang Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Bukwang Pharmaceutical Co. Ltd.
Vanguard Total International Stock Index Fund
378,216
0.77%
0
0%
07/31/2018
Government Pension Fund - Global (The)
324,630
0.66%
-4,430
0%
12/31/2017
iShares Core MSCI Emerging Markets ETF
293,357
0.6%
0
0.01%
09/05/2018
Vanguard Developed Markets Index Fund
151,886
0.31%
0
0%
07/31/2018
Mirae Asset TIGER 200
139,389
0.28%
13,050
0.11%
01/31/2018
Templeton Emerging Markets Small Cap Fund
124,815
0.26%
0
0.32%
03/31/2018
DFA Emerging Markets Small Cap Series
86,264
0.18%
-31,281
0.03%
01/31/2018
Mirae Asset TIGER Health Care ETF
70,295
0.14%
17,200
1.09%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
63,264
0.13%
0
0.02%
07/31/2018
WisdomTree Emerging Markets Small Cap Dividend Fund
59,795
0.12%
0
0.1%
09/06/2018
| Address |
7 Sangdo-ro
Seoul SL 06955
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.bukwang.co.kr |
| Updated |
07/08/2019 |
| Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include gastrointestinal, central nervous system and metabolic drugs. The company also sells household supplies and gift sets. |
